JOSE A LOPEZ-CHEVRES
Allopathic & Osteopathic Physicians|General Practice KISSIMMEE, FL NPI 1598902017
Browse related groups: Allopathic & Osteopathic Physicians|General Practice FL Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,248.95
- Category: General Payments
- Program years: PY2018–2024
- Record count: 58
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $245.42 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $245.42 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168.37 | 4 |
| Lilly USA, LLC | $77.05 | 4 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1118075877 | Boehringer Ingelheim Pharmaceuticals, Inc. | $11.60 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118075879 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.72 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118075881 | Boehringer Ingelheim Pharmaceuticals, Inc. | $24.03 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118075883 | Boehringer Ingelheim Pharmaceuticals, Inc. | $114.02 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135083636 | Lilly USA, LLC | $15.78 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135089455 | Lilly USA, LLC | $22.45 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135089457 | Lilly USA, LLC | $14.82 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135099656 | Lilly USA, LLC | $24.00 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.